GUPEA >
Sahlgrenska Academy / Sahlgrenska akademin >
Institute of Medicine / Institutionen för medicin >
Doctoral Theses / Doktorsavhandlingar Institutionen för medicin >

Clinical aspects of Arteriovenous fistula use in a haemodialysis population. Results based on retrospective and internventional studies.


Please use this identifier to cite or link to this item: http://hdl.handle.net/2077/68316

Files in This Item:

File Description SizeFormat
gupea_2077_68316_1.pdfAbstract255KbAdobe PDF
View/Open
gupea_2077_68316_2.pdfThesis frame6266KbAdobe PDF
View/Open
gupea_2077_68316_3.pdfCover2057KbAdobe PDF
View/Open
Title: Clinical aspects of Arteriovenous fistula use in a haemodialysis population. Results based on retrospective and internventional studies.
Authors: Wärme, Anna
E-mail: anna.warme@vgregion.se
Issue Date: 19-May-2021
University: University of Gothenburg. Sahlgrenska Academy
Institution: Inst of Medicine. Department of Internal Medicine and Clinical Nutrition
Parts of work: I. Hadimeri U, Wärme A, Stegmayr B. A single treatment, using Far Infrared light improves blood flow conditions in arteriovenous fistula. Clin Hemorheol Microcirc. 2017;66(3):211-217.
VIEW ARTICLE


II. Wärme A, Hadimeri U, Hadimeri H, Nasic S, Stegmayr B. High doses of erythropoietin stimulating agents may be a risk factor for AV-fistula stenosis. Clin Hemorheol Microcirc. 2019;71(1):53-57.
VIEW ARTICLE


III. Hadimeri U, Wärme A, Nasic S, Fransson SG, Wigelius A, Stegmayr B. Angiography and phlebography in a hemodialysis population: A retrospective analysis of interventional results. Int J Artif Organs. 2019 Dec;42(12):675-683.
VIEW ARTICLE


IV. Wärme A, Hadimeri H, Nasic S, Stegmayr B. The association of erythropoietin-stimulating agents and increased risk for AV-fistula dysfunction in hemodialysis patients. A retrospective analysis. BMC Nephrology, 22 Article number 30:(2021).
VIEW ARTICLE

Date of Defence: 2021-06-10
Disputation: Torsdagen den 10 juni 2021, kl. 13.00, sal Europa, Konferenscentrum Wallenberg, Medicinaregatan 20A, Göteborg
Degree: Doctor of Philosophy (Medicine)
Publication type: Doctoral thesis
Keywords: Haemodialysis
AV Fistula
Far infrared
Erythropoietin
Abstract: When a patient suffers from end stage renal disease, the vascular access becomes the lifeline to perform regular haemodialysis (HD) treatment. The recommended first choice is the surgically created native Arteriovenous Fistula (AVF). The AVF is exposed for repeated needling when connecting the dialysis machine several times a week. The AVF patency is limited caused by stenosis, aneurysm, and infections. This requires additive interventions, in-hospital care, and sometimes abandonment of the AVF.... more
ISBN: 978-91-8009-181-7 (PDF)
978-91-8009-180-0 (PRINT)
URI: http://hdl.handle.net/2077/68316
Appears in Collections:Doctoral Theses from Sahlgrenska Academy
Doctoral Theses from University of Gothenburg / Doktorsavhandlingar från Göteborgs universitet
Doctoral Theses / Doktorsavhandlingar Institutionen för medicin

 

 

© Göteborgs universitet 2011